|
| Press Releases |
|
 |
|
| Tuesday, October 25, 2016 |
|
|
"京城"- 南台湾唯一获耐震、绿建筑双标章高端豪宅 |
| 台湾实力雄厚及历史悠久的发展商京城建设股份有限公司（简称"京城建设"）宣布，位于高雄市精华地段的顶级豪宅项目「京城」即将于11月上旬全球正式公开发售，单位权状(含公设)面积约由3,470平方呎起至10,003平方呎，售价约由港币1,890万元起，平均呎价约为港币5,350元。 more info >> |
|
|
『京城』- 南台灣唯一獲耐震、綠建築雙標章高端豪宅 |
| 台灣實力雄厚及歷史悠久的發展商京城建設股份有限公司 （簡稱『京城建設』）宣布，位於高雄市精華地段的頂級豪宅項目「京城」即將於11月上旬全球正式公開發售，單位權狀(含公設)面積約由3,470平方呎起至10,003平方呎，售價約由港幣1,890萬元起，平均呎價約為港幣5,350元。 more info >> |
|
|
'King's Residence', the Only Residential Building in Southern Taiwan, Awarded both 'Earthquake Resistance Label' and 'Green Building Label' |
| King's Town Construction Co., Ltd. ("King's Town"), a leading property developer with long history and strong capabilities in Taiwan, today announces the official global sales of the topmost luxury mansion King's Residence in early November. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
